Oral Cancer News | Tag Archive

Success of HPV vaccination is now a matter of coverage

Wednesday, January 4, 2012

Source: The Lancet Oncology, Volume 13, Issue 1, Pages 10-12, January 2012 In a pair of articles in The Lancet Oncology, Lehtinen and colleagues and Wheeler and colleagues present 4-year end of study data from a trial of a prophylactic human papillomavirus (HPV)-16/-18 vaccine (Cervarix, GlaxoSmithKline) in young women aged 15-25 years. From a public-health [...]

Boys need the cervical cancer jab, too

Monday, December 5, 2011

0 Comments

Source: www.telegraph.co.uk Author: Max Pemberton Few politicians will ever admit they are wrong, so I salute health ministers who have finally capitulated to medical opinion and last month announced a U-turn on the cervical cancer vaccine that is given to 12- and 13-year-old girls. Until now, Cervarix, which protects against two strains of the human [...]

HPV vaccine myths put health, lives at risk, say health leaders: Airing the facts

Thursday, December 1, 2011

0 Comments

Source: TheNationsHealth.org Vaccination rates for human papillomavirus are lagging for teens, and a complicated web of confusion and misinformation may be to blame, according to public health leaders. Several strains of HPV can cause cervical cancer, and two vaccines, Gardasil and Cervarix, have been shown conclusively to defend against those strains. The Food and Drug [...]

Use and Acceptance of HPV Vaccine Still a Work in Progress

Wednesday, November 30, 2011

0 Comments

Source: National Cancer Institute A bellwether moment in the history of cancer prevention came in 2006 when the Food and Drug Administration (FDA) approved the first vaccine to prevent cervical cancer. The vaccine, Gardasil, protects against the two primary cancer-causing, or oncogenic, types of the human papillomavirus (HPV)—HPV-16 and HPV-18. These types are responsible for [...]

Trial Confirms Efficacy of HPV Vaccine, Shows Cross-Protection

Tuesday, November 29, 2011

0 Comments

Source: National Cancer Institute End-of-trial results from a trial testing Cervarix, a vaccine against human papillomavirus (HPV) types 16 and 18, showed that the vaccine continued to provide substantial protection against cervical precancers 4 years after vaccination. Cervarix provided almost complete protection in young women who had no evidence of exposure to HPV at the [...]

Data Published in the Lancet Oncology Support High Efficacy Previously Demonstrated By Cervarix

Wednesday, November 16, 2011

0 Comments

Source: Therapeutics Daily Author: Staff LONDON, Nov. 9, 2011-An analysis published today in The Lancet Oncology reinforces previous findings showing that GlaxoSmithKline’s Cervarix®, provided protection against advanced precancerous lesions (CIN3+), above that expected from a vaccine that protects against human papillomavirus (HPV) types 16 and 18. CIN3+ is the immediate step before invasive cervical cancer and data showing protection [...]

HPV Vaccination Could Reduce the Number of Screening Procedures

Tuesday, November 8, 2011

0 Comments

The National Journal By Sophie Quinton Widespread vaccination against cervical cancer could reduce the need for burdensome screenings, U.S. and Finnish researchers said on Tuesday. A study published in the journal Lancet Oncology show that GlaxoSmithKline’s Cervarix vaccine, which protects against two strains of human papillomavirus, or HPV, was more than 93 percent effective in [...]

CDC Committee Recommends Boys Receive HPV Vaccine

Tuesday, October 25, 2011

0 Comments

Source: CNN.com A federal government advisory committee voted Tuesday to recommend that boys and young men, from ages 11 to 21, be vaccinated against the human papilloma virus, commonly referred to as HPV. The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices says the vaccine series can be started as early as [...]

Oral cancers on rise due to HPV

Saturday, October 15, 2011

0 Comments

Source: gargoyle.flagler.edu Author: staff Many Flagler College students are reconsidering human papillomavirus (HPV) vaccines due to the growing number of head and neck cancers in the United States caused by the HPV virus. According to a new study in the Journal of Clinical Oncology, the number of cases of oropharyngeal cancer, which are cancers of [...]

New HPV Study Proves Vaccine’s Effectiveness

Tuesday, September 27, 2011

0 Comments

Source: Cancer.gov A flurry of new research findings on a vaccine that prevents persistent infections by cancer-causing types of the human papillomavirus (HPV) has confirmed the vaccine’s efficacy and opened new avenues for research. The results, published in three separate reports, suggest that the vaccine could be simpler to administer and more affordable than researchers [...]

Tag Archive | "Cervarix"